Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia

被引:119
作者
Hoffmann, JN [1 ]
Vollmar, B
Laschke, MW
Inthorn, D
Fertmann, J
Schildberg, FW
Menger, MD
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Surg, D-8000 Munich, Germany
[2] Univ Saarland, Inst Clin & Expt Surg, D-6650 Homburg, Germany
关键词
sepsis; endotoxemia; microcirculation; protease inhibition;
D O I
10.1097/01.CCM.0000120058.88975.42
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To characterize microcirculatory actions of activated protein C in an endotoxemia rodent model that allows in vivo studies of microvascular inflammation and perfusion dysfunction. Design. Animal study using intravital microscopy. Setting. Animal research facility. Subjects: Male Syrian golden hamsters, 6-8 wks old with a body weight of 60-80 g. Interventions: In skinfold preparations, endotoxemia was induced by intravenous administration of 2 mg/kg endotoxin (lipopolysaccharide, Escherichia coli). Intravital microscopy allowed quantitative analysis of arteriolar and venular leukocyte adhesion and functional capillary density (cm(-1)) that served as a measure of microvascular perfusion failure. Activated protein C (APC group, n = 8, 24 mug/kg intravenously) was substituted continuously during 8 hrs after lipopolysaccharide, whereas endotoxemic buffer-treated animals (control, n = 7) served as controls. Measurements and Main Results. Lipopolysaccharide increased leukocyte adhesion and decreased functional capillary density to 50% of baseline values (p <.01 vs. baseline). Activated protein C treatment inhibited (p <.05) lipopolysaccharide-mediated leukocytic response and attenuated (p <.05) endotoxic perfusion failure in nutritive capillaries. Conclusions: Activated protein C-induced protection from lipopolysaccharide-mediated microcirculatory dysfunction was characterized in vivo for the first time. The impressive modification of leukocyte cross-talk indicates systemic anti-inflammatory activated protein C effects on leukocytes and the endothelium, subsequently improving capillary perfusion. These actions could represent the in vivo mechanism of activated protein C interactions observed in patients with severe sepsis.
引用
收藏
页码:1011 / 1017
页数:7
相关论文
共 45 条
[1]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]   TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK [J].
CREASEY, AA ;
CHANG, ACK ;
FEIGEN, L ;
WUN, TC ;
TAYLOR, FB ;
HINSHAW, LB .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2850-2860
[5]   TECHNICAL REPORT - A NEW CHAMBER TECHNIQUE FOR MICRO-VASCULAR STUDIES IN UNANESTHETIZED HAMSTERS [J].
ENDRICH, B ;
ASAISHI, K ;
GOTZ, A ;
MESSMER, K .
RESEARCH IN EXPERIMENTAL MEDICINE, 1980, 177 (02) :125-134
[6]   The protein C pathway [J].
Esmon, C .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S44-S48
[7]  
Esmon CT, 1999, HAEMATOLOGICA, V84, P254
[8]   Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? [J].
Esmon, CT .
BLOOD, 2000, 95 (04) :1113-1116
[9]   Protein C levels as a prognostic indicator of outcome in sepsis and related diseases [J].
Fisher, CJ ;
Yan, SB .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S49-S56
[10]   SEPTIC SHOCK, MULTIPLE ORGAN FAILURE, AND DISSEMINATED INTRAVASCULAR COAGULATION - COMPARED PATTERNS OF ANTITHROMBIN-III, PROTEIN-C, AND PROTEIN-S DEFICIENCIES [J].
FOURRIER, F ;
CHOPIN, C ;
GOUDEMAND, J ;
HENDRYCX, S ;
CARON, C ;
RIME, A ;
MAREY, A ;
LESTAVEL, P .
CHEST, 1992, 101 (03) :816-823